Brief: Syngene Names Siddharth Mittal As Additional Director, Designated As MD& CEO
27/03/2026 13:30
March 27 (Reuters) - Syngene International Ltd SYNN.NS: RESIGNATION OF PETER BAINS AS MD & CHIEF EXECUTIVE OFFICER APPOINTED SIDDHARTH MITTAL AS ADDITIONAL DIRECTOR, DESIGNATED AS MD& CEO CHANGE OF ROLE OF KIRAN MAZUMDAR SHAW, FROM NON-EXEC CHAIRPERSON TO EXEC CHAIRPERSON Source text: ID:nnAZN4SNOU4 Further company coverage: SYNN.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Syngene International
See all newsBrief: India's Syngene International Posts March-Qtr Consol Profit 1.48 Billion Rupees
Brief: Syngene Names Siddharth Mittal As Additional Director, Designated As MD& CEO
Brief: Syngene International Ltd Says Partial Relief Granted To Company In Tax Appeals
India's Syngene International falls to four-year low after Jefferies' downgrade
India's Syngene International slips after quarterly profit drop